Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection

Vancomycin Bactericidal Activity as a Predictor of 30-Day Mortality in Patients with Methicillin-ResistantStaphylococcus aureusBacteremia

(2011) Motoyasu Miyazaki et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The incidence of heterogeneous vancomycin-intermediate Staphylococcus aureus correlated with increase of vancomycin MIC

(2011) Hongbin Chen et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Methicillin-resistant Staphylococcus aureus bloodstream infections in a Japanese University Hospital between 1987 and 2004

(2011) Tohru Takata et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-IntermediateStaphylococcus aureusIsolates

(2010) Sebastiaan J. van Hal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

(2010) B. P. Howden et al.   CLINICAL MICROBIOLOGY REVIEWS

Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore

(2009) R. K. C. Fong et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years

(2009) A. C. Musta et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Characterization of β-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration

(2009) Yoshio Yamaguchi et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Heterogeneous Vancomycin‐Intermediate Susceptibility Phenotype in Bloodstream Methicillin‐ResistantStaphylococcus aureusIsolates from an International Cohort of Patients with Infective Endocarditis: Prevalence, Genotype, and Clinical Significance

(2009) In‐Gyu Bae et al.   JOURNAL OF INFECTIOUS DISEASES

Clinical Features of Heteroresistant Vancomycin-IntermediateStaphylococcus aureusBacteremia versus Those of Methicillin-ResistantS. aureusBacteremia

(2009) Yasmin Maor et al.   JOURNAL OF INFECTIOUS DISEASES

Rapid Depletion of Free Vancomycin in Medium in the Presence of  -Lactam Antibiotics and Growth Restoration in Staphylococcus aureus Strains with  -Lactam-Induced Vancomycin Resistance

(2008) C. Yanagisawa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin

(2008) T. P. Lodise et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007)

(2008) M. J. Rybak et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Staphylococcus aureusBloodstream Infections: Risk Factors, Outcomes, and the Influence of Methicillin Resistance in Calgary, Canada, 2000–2006

(2008) Kevin B. Laupland et al.   JOURNAL OF INFECTIOUS DISEASES

Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

(2007) A. Soriano et al.   CLINICAL INFECTIOUS DISEASES